| Maris Koester Toland, MD | |
|
5 Washington Pl, Bedford, NH 03110-6736 | |
| (603) 695-2500 | |
| Not Available |
| Full Name | Maris Koester Toland |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 5 Washington Pl, Bedford, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184184442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 23963 (New Hampshire) | Primary |
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the FDA Office of Orphan Products Development has granted orphan drug designation for UX003 for the treatment of MPS 7.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing.
Brooke Webb Masten, featured in Smart for Life broadcast advertising, has maintained her 105-pound weight loss and reached her 3-year milestone. She continues her success by eating Smart for Life cookies, shakes, soups and muffins as well as an exercise routine.
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life, according to a new systematic review.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
› Verified 3 days ago
| Entity Name | Catholic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427154335 PECOS PAC ID: 6103897129 Enrollment ID: O20040803001720 |
News Archive
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the FDA Office of Orphan Products Development has granted orphan drug designation for UX003 for the treatment of MPS 7.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing.
Brooke Webb Masten, featured in Smart for Life broadcast advertising, has maintained her 105-pound weight loss and reached her 3-year milestone. She continues her success by eating Smart for Life cookies, shakes, soups and muffins as well as an exercise routine.
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life, according to a new systematic review.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
› Verified 3 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the FDA Office of Orphan Products Development has granted orphan drug designation for UX003 for the treatment of MPS 7.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing.
Brooke Webb Masten, featured in Smart for Life broadcast advertising, has maintained her 105-pound weight loss and reached her 3-year milestone. She continues her success by eating Smart for Life cookies, shakes, soups and muffins as well as an exercise routine.
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life, according to a new systematic review.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maris Koester Toland, MD 1 Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 650-5000 | Maris Koester Toland, MD 5 Washington Pl, Bedford, NH 03110-6736 Ph: (603) 695-2500 |
News Archive
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the FDA Office of Orphan Products Development has granted orphan drug designation for UX003 for the treatment of MPS 7.
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug Administration on key QUANTA Flash assays for use with Inova Diagnostics' BIO-FLASH chemiluminescent analyzer for autoimmune testing.
Brooke Webb Masten, featured in Smart for Life broadcast advertising, has maintained her 105-pound weight loss and reached her 3-year milestone. She continues her success by eating Smart for Life cookies, shakes, soups and muffins as well as an exercise routine.
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life, according to a new systematic review.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
› Verified 3 days ago
Monica J Chun, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Riverway Pl, Bedford, NH 03110 Phone: 603-668-8400 Fax: 603-626-7368 | |
Jennifer W Weidner, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Riverway Pl, Bedford Commons Obgyn Pa, Bedford, NH 03110 Phone: 603-668-8400 Fax: 603-629-9346 | |
Deborah Enegess, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5 Washington Pl, Bedford, NH 03110 Phone: 603-695-2500 | |
Dr. Linda J. Syiek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 S River Rd, Suite 100, Bedford, NH 03110 Phone: 603-647-0494 Fax: 603-647-0493 | |
Dr. Kenneth R Herr, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 201 Riverway Pl, Bedford, NH 03110 Phone: 603-668-8400 Fax: 603-629-9346 | |
Katlyn Viglianco, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Riverway Pl, Bedford, NH 03110 Phone: 603-668-8400 Fax: 603-626-7368 |